Advancing Complement Approaches to Neurodegenerative Diseases Through Innovative Delivery Strategies to Enable Treatment of CNS Indications
2:00 pm - Wednesday 9th December 2026
- Investigating the role of complement-mediated neuroinflammation in driving neuronal damage across diseases such as Alzheimer’s and Parkinson’s
- Demonstrating how modulation of complement pathways may reduce excessive synaptic pruning, neurodegeneration and chronic inflammation within the central nervous system
- Translating emerging biological insights into target selection, clinical strategies and therapeutic approaches that could improve long-term neurological outcomes
NEW SPEAKING ORGANIZATION
